VIM
ADPT icon

Vinva Investment Management’s Adaptive Biotechnologies ADPT Stock Holding History

Vinva Investment Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$415K Hold
13,358
– – ﹤0.01% 425
2026
Q1 		$250K Buy
13,358
+5,029
+60% +$80.1K ﹤0.01% 426
2025
Q4 		$204K Buy
+8,329
New +$136K ﹤0.01% 395

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vinva Investment Management's ADPT Position: Q2 2026 in Review

Vinva Investment Management held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 13,358 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #425.

Vinva Investment Management first reported a position in ADPT in Q4 2025 and has held it in 3 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Vinva Investment Management held 13,358 shares of Adaptive Biotechnologies worth $415K as of Q2 2026.
  • Vinva Investment Management left its Adaptive Biotechnologies share count unchanged in Q2 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Vinva Investment Management's portfolio in Q2 2026, its #425 holding.
  • Vinva Investment Management first reported a position in Adaptive Biotechnologies in Q4 2025 and has held it in 3 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.